A Pilot Study Evaluating the Effect of Artesunate on Glymphatic‐Related Fluid Transport in Parkinson's Disease Mouse Models In Vivo and Ex Vivo
Open Access
- 16 September 2026
- journal article
- research article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (9) , e71145
Abstract
Aims: Artesunate (ART) has shown neuroprotective potential, but its effects on glymphatic‐related fluid transport in Parkinson's disease (PD) remain unclear. This pilot study aimed to explore whether ART affects glymphatic‐related fluid transport in a PD mouse model and to assess the feasibility of evaluating these changes in vivo. Methods: C57BL/6 WT and A53T mice ( n = 6 each) were divided into four groups (WT, WT + ART, A53T, and A53T + ART) and treated with ART or DMSO for 7 days. Glymphatic‐related fluid transport was assessed by dynamic MRI after intraventricular Gd‐DTPA injection. Immunofluorescence evaluated α‐syn, AQP4, and AQP4‐GFAP colocalization, while transmission electron microscopy (TEM) assessed astrocytic end‐feet integrity. Results: ART was associated with regionally heterogeneous changes in tracer‐related MRI signal dynamics in both WT and A53T mice. In PD mice, ART was associated with partial restoration of AQP4 polarization in selected brain regions and improved perivascular astrocytic end‐feet morphology, accompanied by reduced α‐syn immunofluorescence signal in the substantia nigra. Conclusion: ART was associated with regionally heterogeneous changes in glymphatic‐related fluid transport dynamics and AQP4 polarization in this pilot PD mouse study. These preliminary findings support further investigation of ART as a potential modulator of brain fluid transport‐related pathways in PD.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20230155)
This publication has 47 references indexed in Scilit:
- Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson’s diseaseBiomedicine & Pharmacotherapy, 2023
- Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson’s diseaseJournal of Advanced Research, 2023
- Interaction Between the Glymphatic System and α-Synuclein in Parkinson’s DiseaseMolecular Neurobiology, 2023
- The glymphatic system: Current understanding and modelingiScience, 2022
- The role of AQP4 in the pathogenesis of depression, and possible related mechanismsBrain, Behavior, and Immunity, 2021
- Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial–mesenchymal transitionInternational Immunopharmacology, 2021
- Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging BrainsJAMA Neurology, 2017
- Artesunate Protected Blood–Brain Barrier via Sphingosine 1 Phosphate Receptor 1/Phosphatidylinositol 3 Kinase Pathway After Subarachnoid Hemorrhage in RatsMolecular Neurobiology, 2016
- Artesunate Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by Suppressing TLR4, MyD88 Expression, and NF-κB Activation in Microglial CellsInflammation, 2015
- Peripheral Assessment of the Genes AQP4, PBP and TH in Patients with Parkinson’s DiseaseNeurochemical Research, 2011